MarketPeel
Insider Trading Intelligence
Pricing
…
DP

Dominic Piscitelli

ORIC
CHIEF FINANCIAL OFFICER · ORIC PHARMACEUTICALS, INC. · CIK 0001695028
FILING MIX · LIFETIME40%/60%
BUYS
22
SELLS
33
TOTAL VALUE
$2.31M
COMPANIES
1
ACTIVE SINCE
Apr 2020
HOLDINGS NOW
68,148
AVG SELL PX
$11.23
TRADE KIND
SHOWING 55 / 55
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
18 backtested trades · 8 horizons · 18 pending
Forward-return performance of every backtestable P/S trade by Dominic Piscitelli, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d18+55.56%+3.62%-0.06%+3.67%-1.30%—
14d18+38.89%+7.31%+0.32%+6.99%+2.48%—
30d18+22.22%+16.38%+1.85%+14.53%+11.91%—
60d18+55.56%+1.14%+4.23%-3.09%-8.95%—
90d18+16.67%+9.26%+4.58%+7.41%+2.21%—
180d18(1 pending)+41.18%+4.46%+9.54%-5.08%-8.27%—
1y18(3 pending)+73.33%+16.78%+20.16%-3.38%-35.44%—
2y18(14 pending)+50.00%+120.23%+46.53%+73.70%+102.51%—
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
ORIC · 68,148 shares · as of Feb 24, 2026
051,875103,750155,625207,500202120222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
FLOW · 22 buys / 33 sellsCOVERAGE · 24 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
ORIC
ORIC PHARMACEUTICALS, INC.
PURCHASE
Chief Financial Officer
52,000$4.36$226.7K120,148Feb 24, 2026Feb 26, 2026 ↗View →
ORIC
ORIC PHARMACEUTICALS, INC.
SALE
Chief Financial Officer
52,000——144,500Feb 24, 2026Feb 26, 2026 ↗View →
ORIC
ORIC PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
52,000$13.51$702.7K68,148Feb 24, 2026Feb 26, 2026 ↗View →
ORIC
ORIC PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
34,500——34,500Jan 2, 2026Jan 6, 2026 ↗View →
ORIC
ORIC PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
206,500——206,500Jan 2, 2026Jan 6, 2026 ↗View →
ORIC
ORIC PHARMACEUTICALS, INC.
SALE
Chief Financial Officer
10,720$9.06$97.1K68,148Dec 16, 2025Dec 17, 2025 ↗View →
ORIC
ORIC PHARMACEUTICALS, INC.
PURCHASE
Chief Financial Officer
29,333——78,868Dec 15, 2025Dec 17, 2025 ↗View →
ORIC
ORIC PHARMACEUTICALS, INC.
SALE
Chief Financial Officer
8,000——0Dec 15, 2025Dec 17, 2025 ↗View →
ORIC
ORIC PHARMACEUTICALS, INC.
SALE
Chief Financial Officer
10,000——10,000Dec 15, 2025Dec 17, 2025 ↗View →
ORIC
ORIC PHARMACEUTICALS, INC.
SALE
Chief Financial Officer
11,333——22,667Dec 15, 2025Dec 17, 2025 ↗View →
ORIC
ORIC PHARMACEUTICALS, INC.
SALE
Chief Financial Officer
11,000——196,500Oct 6, 2025Oct 8, 2025 ↗View →
ORIC
ORIC PHARMACEUTICALS, INC.
PURCHASE
Chief Financial Officer
11,000$4.36$48.0K59,317Oct 6, 2025Oct 8, 2025 ↗View →
ORIC
ORIC PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
11,000$14.52$159.7K48,317Oct 6, 2025Oct 8, 2025 ↗View →
ORIC
ORIC PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
20,000$10.05$201.0K48,317Jul 1, 2025Jul 2, 2025 ↗View →
ORIC
ORIC PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
32,466$10.50$341.0K68,317Jun 24, 2025Jun 24, 2025 ↗View →
ORIC
ORIC PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
584$10.00$5.8K101,233Jun 23, 2025Jun 24, 2025 ↗View →
ORIC
ORIC PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
450$10.01$4.5K100,783Jun 23, 2025Jun 24, 2025 ↗View →
ORIC
ORIC PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
300$10.00$3.0K101,817Jun 12, 2025Jun 13, 2025 ↗View →
ORIC
ORIC PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
1,276$10.00$12.8K103,817Jun 11, 2025Jun 11, 2025 ↗View →
ORIC
ORIC PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
1,700$10.01$17.0K102,117Jun 11, 2025Jun 11, 2025 ↗View →
ORIC
ORIC PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
324$10.00$3.2K105,093Jun 10, 2025Jun 11, 2025 ↗View →
ORIC
ORIC PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
300$10.00$3.0K103,864Jun 9, 2025Jun 9, 2025 ↗View →
ORIC
ORIC PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
2,600$10.01$26.0K104,164Jun 6, 2025Jun 9, 2025 ↗View →
ORIC
ORIC PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
202,500——202,500Jan 2, 2025Jan 3, 2025 ↗View →
ORIC
ORIC PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
34,000——34,000Jan 2, 2025Jan 3, 2025 ↗View →
ORIC
ORIC PHARMACEUTICALS, INC.
SALE
Chief Financial Officer
8,851$8.28$73.3K106,764Dec 16, 2024Dec 17, 2024 ↗View →
ORIC
ORIC PHARMACEUTICALS, INC.
SALE
Chief Financial Officer
10,000——20,000Dec 15, 2024Dec 17, 2024 ↗View →
ORIC
ORIC PHARMACEUTICALS, INC.
PURCHASE
Chief Financial Officer
24,042——115,615Dec 15, 2024Dec 17, 2024 ↗View →
ORIC
ORIC PHARMACEUTICALS, INC.
SALE
Chief Financial Officer
8,000——8,000Dec 15, 2024Dec 17, 2024 ↗View →
ORIC
ORIC PHARMACEUTICALS, INC.
SALE
Chief Financial Officer
6,042——0Dec 15, 2024Dec 17, 2024 ↗View →
ORIC
ORIC PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
30,000——30,000Jan 2, 2024Jan 3, 2024 ↗View →
ORIC
ORIC PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
180,000——180,000Jan 2, 2024Jan 3, 2024 ↗View →
ORIC
ORIC PHARMACEUTICALS, INC.
SALE
Chief Financial Officer
14,042——89,091Dec 15, 2023Dec 19, 2023 ↗View →
ORIC
ORIC PHARMACEUTICALS, INC.
SALE
Chief Financial Officer
8,000——16,000Dec 15, 2023Dec 19, 2023 ↗View →
ORIC
ORIC PHARMACEUTICALS, INC.
SALE
Chief Financial Officer
5,282$8.58$45.3K83,809Dec 15, 2023Dec 19, 2023 ↗View →
ORIC
ORIC PHARMACEUTICALS, INC.
SALE
Chief Financial Officer
6,042——6,042Dec 15, 2023Dec 19, 2023 ↗View →
ORIC
ORIC PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
145,000——145,000Feb 1, 2023Feb 2, 2023 ↗View →
ORIC
ORIC PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
24,000——24,000Feb 1, 2023Feb 2, 2023 ↗View →
ORIC
ORIC PHARMACEUTICALS, INC.
SALE
Chief Financial Officer
2,227$3.08$6.9K67,285Dec 15, 2022Feb 17, 2023 ↗View →
ORIC
ORIC PHARMACEUTICALS, INC.
SALE
Chief Financial Officer
6,041——12,084Dec 15, 2022Dec 16, 2022 ↗View →
ORIC
ORIC PHARMACEUTICALS, INC.
PURCHASE
Chief Financial Officer
6,041——69,512Dec 15, 2022Dec 16, 2022 ↗View →
ORIC
ORIC PHARMACEUTICALS, INC.
SALE
Chief Financial Officer
2,089$3.25$6.8K67,423Dec 15, 2022Dec 16, 2022 ↗View →
ORIC
ORIC PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
90,000——90,000Jul 20, 2022Jul 21, 2022 ↗View →
ORIC
ORIC PHARMACEUTICALS, INC.
SALE
Chief Financial Officer
207,500——0Jul 20, 2022Jul 21, 2022 ↗View →
ORIC
ORIC PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
207,500——207,500Jul 20, 2022Jul 21, 2022 ↗View →
ORIC
ORIC PHARMACEUTICALS, INC.
SALE
Chief Financial Officer
108,750——0Jul 20, 2022Jul 21, 2022 ↗View →
ORIC
ORIC PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
108,750——108,750Jul 20, 2022Jul 21, 2022 ↗View →
ORIC
ORIC PHARMACEUTICALS, INC.
SALE
Chief Financial Officer
86,250——0Jul 20, 2022Jul 21, 2022 ↗View →
ORIC
ORIC PHARMACEUTICALS, INC.
SALE
Chief Financial Officer
90,000——0Jul 20, 2022Jul 21, 2022 ↗View →
ORIC
ORIC PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
86,250——86,250Jul 20, 2022Jul 21, 2022 ↗View →
ORIC
ORIC PHARMACEUTICALS, INC.
PURCHASE
Chief Financial Officer
60,000$5.36$321.6K60,000Mar 31, 2022Mar 31, 2022 ↗View →
ORIC
ORIC PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
108,750——108,750Feb 1, 2022Feb 2, 2022 ↗View →
ORIC
ORIC PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
18,125——18,125Feb 1, 2022Feb 2, 2022 ↗View →
ORIC
ORIC PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
90,000——90,000Feb 1, 2021Feb 2, 2021 ↗View →
ORIC
ORIC PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
86,250——86,250Apr 23, 2020Apr 27, 2020 ↗View →
Other insiders · ORIC
Loading peer insiders…
About this filer
CIK 0001695028
ROLE
Chief Financial Officer
PRIMARY
ORIC
COMPANIES
1
ACTIVE SINCE
Apr 2020
MARKETPEEL · /INSIDER/0001695028DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback